155 related articles for article (PubMed ID: 1381241)
61. Synergy of IL-1 and stem cell factor in radioprotection of mice is associated with IL-1 up-regulation of mRNA and protein expression for c-kit on bone marrow cells.
Neta R; Oppenheim JJ; Wang JM; Snapper CM; Moorman MA; Dubois CM
J Immunol; 1994 Aug; 153(4):1536-43. PubMed ID: 7519205
[TBL] [Abstract][Full Text] [Related]
62. Lack of KIT or FMS internal tandem duplications but co-expression with ligands in AML.
Zheng R; Klang K; Gorin NC; Small D
Leuk Res; 2004 Feb; 28(2):121-6. PubMed ID: 14654075
[TBL] [Abstract][Full Text] [Related]
63. Gene expression from the c-erbA alpha/Rev-ErbA alpha genomic locus. Potential regulation of alternative splicing by opposite strand transcription.
Lazar MA; Hodin RA; Cardona G; Chin WW
J Biol Chem; 1990 Aug; 265(22):12859-63. PubMed ID: 2165488
[TBL] [Abstract][Full Text] [Related]
64. Relationship of acivicin-induced monocytoid differentiation of human myeloid leukemia cells to acivicin-induced modulation of growth factor, cytokine, and protooncogene mRNA expression.
Weinberg JB; Mason SN
Cancer Res; 1991 Feb; 51(4):1202-9. PubMed ID: 1997162
[TBL] [Abstract][Full Text] [Related]
65. Transforming growth factor-beta relieves stem cell factor-induced proliferation of myelogenous leukemia cells through inhibition of binding of the transcription factor NF-jun.
Sott C; Dorner B; Karawajew L; Herrmann F; Brach MA
Blood; 1994 Sep; 84(6):1950-9. PubMed ID: 7521696
[TBL] [Abstract][Full Text] [Related]
66. Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alpha.
Brach MA; Gruss HJ; Asano Y; de Vos S; Ludwig WD; Mertelsmann R; Herrmann F
Cancer Res; 1992 Apr; 52(8):2197-201. PubMed ID: 1373106
[TBL] [Abstract][Full Text] [Related]
67. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
68. Recombinant human tumor necrosis factor alpha regulates c-myc expression in HL-60 cells at the level of transcription.
Tobler A; Johnston D; Koeffler HP
Blood; 1987 Jul; 70(1):200-5. PubMed ID: 3474039
[TBL] [Abstract][Full Text] [Related]
69. The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells.
Spiekermann K; Faber F; Voswinckel R; Hiddemann W
Exp Hematol; 2002 Jul; 30(7):767-73. PubMed ID: 12135675
[TBL] [Abstract][Full Text] [Related]
70. The SCF and c-kit genes in Diamond-Blackfan anemia.
Drachtman RA; Geissler EN; Alter BP
Blood; 1992 Apr; 79(8):2177-8. PubMed ID: 1373335
[No Abstract] [Full Text] [Related]
71. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
Beghini A; Cairoli R; Morra E; Larizza L
Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
[TBL] [Abstract][Full Text] [Related]
72. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
73. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
[TBL] [Abstract][Full Text] [Related]
74. Expression of cellular oncogenes in primary cells from human acute leukemias.
Mavilio F; Sposi NM; Petrini M; Bottero L; Marinucci M; De Rossi G; Amadori S; Mandelli F; Peschle C
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4394-8. PubMed ID: 3520570
[TBL] [Abstract][Full Text] [Related]
75. High expression of c-kit in K562YO cells due to the prolonged half-life of its mRNA: the effects of modification with serine/threonine kinase signals.
Ogawa K; Takeda Y; Tashima M; Sawai H; Toi T; Okazaki T; Sawada H; Maruyama Y; Okuma M
Blood; 1995 Mar; 85(6):1496-503. PubMed ID: 7534132
[TBL] [Abstract][Full Text] [Related]
76. c-KIT expression enhances the leukemogenic potential of 32D cells.
Hu Q; Trevisan M; Xu Y; Dong W; Berger SA; Lyman SD; Minden MD
J Clin Invest; 1995 Jun; 95(6):2530-8. PubMed ID: 7539453
[TBL] [Abstract][Full Text] [Related]
77. A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses.
Lev S; Yarden Y; Givol D
J Biol Chem; 1992 May; 267(15):10866-73. PubMed ID: 1375232
[TBL] [Abstract][Full Text] [Related]
78. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA
Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
[TBL] [Abstract][Full Text] [Related]
79. c-kit expression in human megakaryoblastic leukemia cell lines.
Hu ZB; Ma W; Uphoff CC; Quentmeier H; Drexler HG
Blood; 1994 Apr; 83(8):2133-44. PubMed ID: 7512841
[TBL] [Abstract][Full Text] [Related]
80. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
